Cognitive-Behavioral Therapy for Insomnia Tailored to Patients With Cardiovascular Disease: A Pre-Post Study
Overview
Affiliations
: There is little research assessing the use of cognitive-behavioral therapy for insomnia (CBT-I) among patients with cardiovascular disease (CVD), even less on the effects of CBT-I on CVD risk factors such as anxiety and depression, and to our knowledge, only limited studies of the efficacy of CBT-I protocols with cardiac disease-specific modifications. The objective of this study is to evaluate a group-based CBT-I intervention tailored to patients with CVD on sleep quality, duration, and mental health. : A sample of 47 participants (25 men) diagnosed with primary insomnia were included in this study. : This study used a pre-post design comparing outcomes before and after a group intervention. Clinicians in a cardiac center referred CVD patients with self-reported sleep disturbance to the intervention group. Following screening and confirmation of insomnia disorder, participants completed a six-week CBT-I group-based intervention tailored for patients with CVD. Participants completed sleep diaries and questionnaires, including the Insomnia Severity Index, Beck Depression Inventory-II, and Beck Anxiety Inventory, pre- and postintervention. : Participants' sleep outcomes (sleep duration, maintenance, efficiency, latency, and quality) were significantly improved and patients reported significantly fewer symptoms of anxiety, depression, and insomnia following the CBT-I intervention ( values < .05). : After participating in a CBT-I group intervention tailored for cardiac patients, patients reported improved sleep and significantly lower levels of anxiety and depression. Randomized trials of this intervention are warranted.
Stapel B, Alvarenga M, Kahl K Front Psychiatry. 2025; 16:1490585.
PMID: 40018681 PMC: 11865029. DOI: 10.3389/fpsyt.2025.1490585.
Tighe C, Phares A, Weiner D, Beehler G, VanSwearingen J, Harvey A Behav Sleep Med. 2024; 22(6):894-909.
PMID: 39120442 PMC: 11632399. DOI: 10.1080/15402002.2024.2386602.
Eshera Y, Gavrilova L, Hughes J Am J Lifestyle Med. 2024; 18(3):340-350.
PMID: 38737888 PMC: 11082862. DOI: 10.1177/15598276231211846.
Stallman H, Lushington K, Varcoe T Contemp Clin Trials Commun. 2023; 36:101230.
PMID: 38034841 PMC: 10684365. DOI: 10.1016/j.conctc.2023.101230.
Oberg S, Johansson L, Georgsson M, Sandberg J, Brostrom A Nurs Open. 2023; 10(7):4676-4689.
PMID: 36929685 PMC: 10277389. DOI: 10.1002/nop2.1717.